Evaluation of Neuropathic Extremity Pain in Patients with Multiple Sclerosis

Key Findings & Data:For the evaluation of neuropathic pain Leeds assessment of neuropathic symptoms and signs (LANSS) and douleur neuropathique 4 questions (DN4) were used.

💡

Conclusion & Impact:All patients with the diagnosis of MS should be evaluated for neuropathic pain.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Introduction: Neuropathic extremity pain is one of the most common symptoms of multiple sclerosis (MS). This study was aimed to evaluate and compare the frequency and severity of neuropathic extremity pain in subtypes of MS. Methods: Patients with the diagnosis of MS were included in the study, consecutively. Patients’ demographic and clinical data were recorded. Patients’ pain severity was assessed with visual analog scale (VAS). For the evaluation of neuropathic pain Leeds assessment of neuropathic symptoms and signs (LANSS) and douleur neuropathique 4 questions (DN4) were used. Disability was assessed with the Extended Disability Status Scale (EDSS). Results: One hundred and three patients were included and 82.5% of them had relapsing-remitting (RR) MS. According to LANSS and DN4, 47.6% of patients had neuropathic pain. Female patients had significantly higher pain scores. There was no significant difference between the subtypes of MS based on having neuropathic pain. Patients with seconder progressive (SP) MS had significantly higher EDSS. A significant positive correlation was detected between EDSS score and duration of disease. Conclusion: Regardless of the MS subtype patients had neuropathic pain. Patients with SP had significantly higher disease duration and EDSS which were correlated with each other. All patients with the diagnosis of MS should be evaluated for neuropathic pain.

Özet

Amaç: Nöropatik ekstremite ağrısı Multiple sklerozda (MS) en sık görülensemptomlardan biridir. Bu çalışmada MS alt tiplerinde görülen nöropatikağrının sıklığı ve şiddetini değerlendirip karşılaştırmak amaçlanmıştır.Yöntem: MS tanısı ile başvuran hastalar ardışık olarak çalışmayadâhil edilmiştir. Klinik ve demografik verileri kayıt edilmiştir. Ağrıyıdeğerlendirmek için Vizuel Analog Skala (VAS) kullanılmıştır. Nöropatikağrının değerlendirilmesi için hastalara LANSS ağrı skalası ile 4 sorunöropatik ağrı anketi (DN4) uygulanmıştır. Genişletilmiş özürlülükdurumu ölçeği ile dizabilite değerlendirilmiştir.Bulgular: Çalışmaya 103 hasta dahil edilmiş olup bunların %82, 5’inderelapsing-remitting (RR) tip MS mevcuttu. LANSS ve DN4’e görehastaların %47,6’sında nöropatik ağrı mevcuttu. Kadın hastaların ağrıskorları anlamlı derecede yüksekti. MS alt tipleri arasında nöropatik ağrıvarlığı açısından anlamlı farklılık saptanmadı. Sekonder progresif (SP)MS alt tipinde hastaların EDSS skroları anlamlı derecede yüksekti. EDSSskoru ile hastalık süresi arasında anlamlı pozitif korelasyon mevcuttu.Sonuç: MS alt tipi fark etmeksizin MS’de nöropatik ağrı sıklıklagörülmektedir. SP MS’li hastaların EDSS skorları ve hastalık süreleri dahayüksektir ve bu iki parametre birbiri ile koreledir. MS tanısı alan tümhastalar nöropatik ağrı açısından değerlendirilmelidir.

🔖

Cite This Article

ATA, E., UNUBOL, T. O., DEMİR, S. (2021). Evaluation of Neuropathic Extremity Pain in Patients with Multiple Sclerosis. Nöropsikiyatri Arşivi, Cilt: 58 - Sayı: 3, 213–216. https://ajindex.com/articles/340795

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med. 343 (13):938-952. [Crossref] 2. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83 (3):278-286. [Crossref] 3. Aydede M (2017) Defending the IASP definition of pain. The Monist 100 (4):439-464 [Crossref] 4. Kumar KH, Elavarasi P (2016) Definition of pain and classification of pain disorders. Journal of Advanced Clinical and Research Insights 3 (3):87-90 [Crossref] 5. Truini A, Barbanti P, Pozzilli C, Cruccu G (2013) A mechanism-based classification of pain in multiple sclerosis. J Neurol. 260 (2):351-367 [Crossref] 6. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 69 (2):292-302 [Crossref] 7. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (11):1444-1444 [Crossref] 8. Bennett M (2001) The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 92 (1-2):147-157 9. Yucel A, Senocak M, Orhan EK, Cimen A, Ertas M (2004) Results of the Leeds assessment of neuropathic symptoms and signs pain scale in Turkey: a validation study. J Pain 5 (8):427-432. [Crossref] 10. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114 (1-2):29- 36. [Crossref] 11. O’Connor AB, Schwid SR, Herrmann DN, Markman JD, Dworkin RH (2008) Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 137 (1):96-111. [Crossref] 12. Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, Benoliel R, Cohen M, Cruccu G, Davis KD, Evers S, First M, Giamberardino MA, Hansson P, Kaasa S, Korwisi B, Kosek E, Lavand’homme P, Nicholas M, Nurmikko T, Perrot S, Raja SN, Rice ASC, Rowbotham MC, Schug S, Simpson DM, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ, Barke A, Rief W, Treede RD (2019) The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain 160 (1):53-59. [Crossref] 13. Foley PL, Vesterinen HM,